Fig. 1From: A bioreactor system for the manufacture of a genetically modified Plasmodium falciparum blood stage malaria cell bank for use in a clinical trialProcess overview. The steps involved in production of the 3D7 KAHRP-KO GAP master cell bankBack to article page